Skip to content
Screener

Haemonetics HAE Q1 2027 earnings

Reported August 6, 2026 · Before market open

Revenue$339.4MBeat by $11.5M
EPS$1.14Beat by $0.06
Revenue estimate$327.9M
EPS estimate$1.08
“We had a strong start to fiscal 2027, gaining Plasma share, sustaining Blood Management Technologies momentum, and returning Interventional Technologies to growth. With our evolved portfolio, transformed operating model and disciplined execution, we are strengthening our competitive position and demonstrating the durable growth of our diversified businesses. We raised full-year guidance, and Haemonetics is well-positioned to deliver sustainable long-term growth and shareholder value.”
Chris Simon

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$345.0M
EPS estimate$1.30

Financials

Q1 2027

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$4.83B+101%
Enterprise value$5.78B+73.3%
P/E32.1×—
P/S3.6×+1.8×

Profitability

See full
Gross margin59%+2.1pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Segments

By product

See full
Plasma$155.5M+7.2%
Blood Management Technologies$88.1M—
Interventional Technologies$59.9M—

By segment

See full
Apheresis$191.3M—
MedSurg$148.1M—

By geography

See full
Other$35.8M-2.4%

FAQ

When did Haemonetics report Q1 2027 earnings?
Haemonetics (HAE) reported Q1 2027 earnings on August 6, 2026 before market open.
What were Haemonetics's Q1 2027 revenue and EPS?
Haemonetics reported revenue of $339.4M and eps of $1.14 for Q1 2027.
Did Haemonetics beat estimates in Q1 2027?
Revenue beat the consensus estimate of $327.9M by $11.5M. EPS beat the consensus estimate of $1.08 by $0.06.
How did Haemonetics's Q1 2027 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.6% from $321.4M a year earlier and eps grew 3.6% from $1.10.
Where can I find Haemonetics's Q1 2027 SEC filings?
You can read the 8-K earnings release (0000313143-26-000118) and the 10-Q periodic report (0000313143-26-000120) directly on SEC EDGAR. The filing index links above go to sec.gov.